(-)-demecolcine increases expression ISO RGD:735485 6480464 Demecolcine results in increased expression of MARCKS mRNA CTD PMID:23649840 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of MARCKS mRNA CTD PMID:27840820 1,2-dimethylhydrazine multiple interactions ISO RGD:10881 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MARCKS mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:10881 6480464 1, 2-Dimethylhydrazine results in decreased expression of MARCKS mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:735485 6480464 Dinitrochlorobenzene results in increased expression of MARCKS mRNA CTD PMID:16314067 17alpha-ethynylestradiol affects expression ISO RGD:10881 6480464 Ethinyl Estradiol affects the expression of MARCKS mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:10881 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MARCKS mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:735485 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MARCKS mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of MARCKS mRNA CTD PMID:17404688 , PMID:20660070 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of MARCKS mRNA CTD PMID:17010207 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:735485 6480464 Dihydrotestosterone results in increased expression of MARCKS mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10881 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MARCKS mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA] CTD PMID:16054899 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MARCKS mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MARCKS mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MARCKS mRNA CTD PMID:20959002 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10881 6480464 Tetrachlorodibenzodioxin affects the expression of MARCKS mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735485 6480464 Tetrachlorodibenzodioxin results in decreased expression of MARCKS mRNA CTD PMID:19692669 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10881 6480464 Tetrachlorodibenzodioxin results in decreased expression of MARCKS mRNA CTD PMID:15652763 , PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:735485 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10881 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA more ... CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735485 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MARCKS mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:10881 6480464 Methylcholanthrene results in decreased expression of MARCKS mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of MARCKS mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:735485 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MARCKS protein CTD PMID:34186270 5-fluorouracil decreases expression ISO RGD:735485 6480464 Fluorouracil results in decreased expression of MARCKS mRNA CTD PMID:17039268 5-fluorouracil affects response to substance ISO RGD:735485 6480464 MARCKS protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MARCKS mRNA CTD PMID:24780913 , PMID:30047161 6alpha-methylprednisolone decreases expression ISO RGD:735485 6480464 Methylprednisolone results in decreased expression of MARCKS mRNA CTD PMID:19192274 acetamide increases expression EXP 6480464 acetamide results in increased expression of MARCKS mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MARCKS mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:735485 6480464 Aflatoxin B1 affects the expression of MARCKS protein CTD PMID:20106945 alachlor increases expression EXP 6480464 alachlor results in increased expression of MARCKS mRNA CTD PMID:12419858 all-trans-retinoic acid increases expression ISO RGD:735485 6480464 Tretinoin results in increased expression of MARCKS mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of MARCKS mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MARCKS mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:735485 6480464 aristolochic acid I results in decreased expression of MARCKS mRNA, aristolochic acid I results in decreased expression of MARCKS protein CTD PMID:33212167 aristolochic acids increases expression EXP 6480464 Aristolochic Acids results in increased expression of MARCKS mRNA CTD PMID:19717638 arsenous acid increases expression ISO RGD:735485 6480464 Arsenic Trioxide results in increased expression of MARCKS protein CTD PMID:25419056 azathioprine decreases expression ISO RGD:735485 6480464 Azathioprine results in decreased expression of MARCKS mRNA CTD PMID:19192274 benzo[a]pyrene decreases expression ISO RGD:10881 6480464 Benzo(a)pyrene results in decreased expression of MARCKS mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:735485 6480464 Benzo(a)pyrene results in increased expression of MARCKS mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:735485 6480464 Benzo(a)pyrene results in increased methylation of MARCKS promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:735485 6480464 Benzo(a)pyrene results in decreased methylation of MARCKS 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10881 6480464 Benzo(a)pyrene results in increased expression of MARCKS mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735485 6480464 7 more ... CTD PMID:19150397 more ... bis(2-chloroethyl) sulfide increases expression ISO RGD:10881 6480464 Mustard Gas results in increased expression of MARCKS mRNA CTD PMID:15674844 bisphenol A decreases expression ISO RGD:10881 6480464 bisphenol A results in decreased expression of MARCKS mRNA CTD PMID:17706920 bisphenol A increases expression ISO RGD:735485 6480464 bisphenol A results in increased expression of MARCKS mRNA, bisphenol A results in increased expression of MARCKS protein CTD PMID:29718440 , PMID:34186270 bisphenol A multiple interactions ISO RGD:735485 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MARCKS mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MARCKS mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A multiple interactions ISO RGD:10881 6480464 LHB protein affects the reaction [bisphenol A results in decreased expression of MARCKS mRNA] CTD PMID:17706920 Bisphenol B increases expression ISO RGD:735485 6480464 bisphenol B results in increased expression of MARCKS protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:735485 6480464 bisphenol F results in increased expression of MARCKS protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of MARCKS protein CTD PMID:25933445 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of MARCKS protein CTD PMID:28903499 cadmium dichloride multiple interactions ISO RGD:10881 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MARCKS mRNA CTD PMID:19840844 caffeine affects phosphorylation ISO RGD:735485 6480464 Caffeine affects the phosphorylation of MARCKS protein CTD PMID:35688186 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of MARCKS mRNA CTD PMID:17293106 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of MARCKS mRNA CTD PMID:20349343 carbamazepine increases phosphorylation EXP 6480464 Carbamazepine results in increased phosphorylation of MARCKS protein CTD PMID:14642444 carbon nanotube increases expression ISO RGD:10881 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:735485 6480464 CGP 52608 promotes the reaction [RORA protein binds to MARCKS gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:735485 6480464 chloropicrin results in decreased expression of MARCKS mRNA CTD PMID:26352163 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of MARCKS mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:10881 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MARCKS mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:10881 6480464 Ciguatoxins affects the expression of MARCKS mRNA CTD PMID:18353800 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of MARCKS mRNA CTD PMID:30047161 cobalt dichloride decreases expression ISO RGD:735485 6480464 cobaltous chloride results in decreased expression of MARCKS mRNA CTD PMID:19320972 copper atom decreases expression ISO RGD:735485 6480464 Copper results in decreased expression of MARCKS mRNA CTD PMID:19747488 copper(0) decreases expression ISO RGD:735485 6480464 Copper results in decreased expression of MARCKS mRNA CTD PMID:19747488 copper(II) sulfate decreases expression ISO RGD:735485 6480464 Copper Sulfate results in decreased expression of MARCKS mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:735485 6480464 coumarin results in decreased phosphorylation of MARCKS protein CTD PMID:35688186 coumestrol decreases expression ISO RGD:735485 6480464 Coumestrol results in decreased expression of MARCKS mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:10881 6480464 Asbestos, Crocidolite results in decreased expression of MARCKS mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MARCKS mRNA CTD PMID:27523638 cyclophosphamide increases expression ISO RGD:735485 6480464 Cyclophosphamide results in increased expression of MARCKS mRNA CTD PMID:17403535 cyclosporin A decreases expression ISO RGD:10881 6480464 Cyclosporine results in decreased expression of MARCKS mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:735485 6480464 Cyclosporine results in decreased expression of MARCKS mRNA CTD PMID:25562108 deguelin decreases expression ISO RGD:735485 6480464 deguelin results in decreased expression of MARCKS mRNA CTD PMID:33512557 deoxynivalenol increases phosphorylation ISO RGD:10881 6480464 deoxynivalenol results in increased phosphorylation of MARCKS protein CTD PMID:23811945 dexamethasone multiple interactions ISO RGD:10881 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of MARCKS mRNA more ... CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:735485 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MARCKS mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:735485 6480464 Dexamethasone results in decreased expression of MARCKS mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO RGD:735485 6480464 Arsenic Trioxide results in increased expression of MARCKS protein CTD PMID:25419056 dibenz[a,h]anthracene increases expression ISO RGD:10881 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:10881 6480464 Dibutyl Phthalate results in decreased expression of MARCKS mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MARCKS mRNA CTD PMID:17379624 more ... diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of MARCKS mRNA CTD PMID:17010207 diethylstilbestrol increases expression ISO RGD:735485 6480464 Diethylstilbestrol results in increased expression of MARCKS mRNA CTD PMID:36621641 diquat decreases expression ISO RGD:10881 6480464 Diquat results in decreased expression of MARCKS mRNA CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MARCKS mRNA CTD PMID:25152437 divanadium pentaoxide decreases expression ISO RGD:735485 6480464 vanadium pentoxide results in decreased expression of MARCKS mRNA CTD PMID:17459161 dopamine increases expression ISO RGD:735485 6480464 Dopamine results in increased expression of MARCKS protein CTD PMID:24675778 doxorubicin decreases expression ISO RGD:735485 6480464 Doxorubicin results in decreased expression of MARCKS mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:735485 6480464 Selenium results in increased expression of MARCKS mRNA CTD PMID:19244175 entinostat decreases expression ISO RGD:735485 6480464 entinostat results in decreased expression of MARCKS mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:735485 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MARCKS protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MARCKS protein CTD PMID:24646710 folic acid multiple interactions ISO RGD:10881 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan increases expression EXP 6480464 furan results in increased expression of MARCKS mRNA CTD PMID:26194646 , PMID:27387713 gemcitabine increases expression ISO RGD:735485 6480464 Gemcitabine results in increased expression of MARCKS mRNA CTD PMID:17039268 gemcitabine increases phosphorylation ISO RGD:735485 6480464 Gemcitabine results in increased phosphorylation of MARCKS protein CTD PMID:9523737 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MARCKS mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MARCKS mRNA CTD PMID:33387578 hexadecanoic acid decreases phosphorylation ISO RGD:735485 6480464 Palmitic Acid results in decreased phosphorylation of MARCKS protein CTD PMID:28073184 hydrogen peroxide multiple interactions ISO RGD:10881 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO RGD:735485 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MARCKS mRNA CTD PMID:28628672 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of MARCKS mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of MARCKS mRNA CTD PMID:16629162 ivermectin decreases expression ISO RGD:735485 6480464 Ivermectin results in decreased expression of MARCKS protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:10881 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MARCKS mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of MARCKS mRNA, lead acetate results in decreased expression of MARCKS protein CTD PMID:11578147 linalool increases expression EXP 6480464 linalool results in increased expression of MARCKS mRNA CTD PMID:20536181 lipopolysaccharide increases expression ISO RGD:735485 6480464 Lipopolysaccharides results in increased expression of MARCKS mRNA CTD PMID:18192897 , PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:735485 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MARCKS mRNA more ... CTD PMID:35811015 , PMID:35877022 methotrexate affects expression ISO RGD:10881 6480464 Methotrexate affects the expression of MARCKS mRNA CTD PMID:18502557 methotrexate decreases expression ISO RGD:735485 6480464 Methotrexate results in decreased expression of MARCKS mRNA CTD PMID:19192274 methyl methanesulfonate decreases expression ISO RGD:735485 6480464 Methyl Methanesulfonate results in decreased expression of MARCKS mRNA CTD PMID:23649840 methyllycaconitine increases phosphorylation ISO RGD:735485 6480464 methyllycaconitine results in increased phosphorylation of MARCKS protein CTD PMID:24012499 methylparaben decreases expression ISO RGD:735485 6480464 methylparaben results in decreased expression of MARCKS mRNA CTD PMID:31745603 morphine decreases expression EXP 6480464 Morphine results in decreased expression of MARCKS protein CTD PMID:23056601 N-methyl-4-phenylpyridinium increases expression ISO RGD:735485 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MARCKS protein CTD PMID:24675778 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:10881 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of MARCKS mRNA more ... CTD PMID:19840844 nickel atom increases expression ISO RGD:735485 6480464 Nickel results in increased expression of MARCKS mRNA CTD PMID:23195993 nickel sulfate increases expression ISO RGD:735485 6480464 nickel sulfate results in increased expression of MARCKS mRNA CTD PMID:16314067 O-methyleugenol increases expression ISO RGD:735485 6480464 methyleugenol results in increased expression of MARCKS mRNA CTD PMID:32234424 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of MARCKS mRNA CTD PMID:19717638 okadaic acid multiple interactions ISO RGD:10881 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of MARCKS mRNA CTD PMID:19840844 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MARCKS mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:735485 6480464 oxaliplatin results in increased expression of MARCKS mRNA CTD PMID:17762391 ozone decreases expression EXP 6480464 Ozone results in decreased expression of MARCKS mRNA CTD PMID:16330353 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of MARCKS mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:10881 6480464 Acetaminophen affects the expression of MARCKS mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735485 6480464 Acetaminophen results in increased expression of MARCKS mRNA CTD PMID:29067470 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 pentachlorophenol decreases expression ISO RGD:10881 6480464 Pentachlorophenol results in decreased expression of MARCKS mRNA CTD PMID:23892564 phenobarbital affects expression ISO RGD:10881 6480464 Phenobarbital affects the expression of MARCKS mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10881 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARCKS mRNA CTD PMID:19840844 pirinixic acid decreases expression ISO RGD:10881 6480464 pirinixic acid results in decreased expression of MARCKS mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:10881 6480464 pirinixic acid results in increased expression of MARCKS mRNA CTD PMID:23811191 piroxicam decreases expression ISO RGD:735485 6480464 Piroxicam results in decreased expression of MARCKS mRNA CTD PMID:19192274 prednisolone decreases expression ISO RGD:735485 6480464 Prednisolone results in decreased expression of MARCKS mRNA CTD PMID:19192274 progesterone multiple interactions ISO RGD:735485 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of MARCKS mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of MARCKS mRNA CTD PMID:17404688 , PMID:20660070 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of MARCKS mRNA CTD PMID:20726854 progesterone decreases expression ISO RGD:735485 6480464 Progesterone results in decreased expression of MARCKS mRNA CTD PMID:17404688 rotenone increases expression ISO RGD:735485 6480464 Rotenone results in increased expression of MARCKS mRNA CTD PMID:36586010 rottlerin multiple interactions ISO RGD:10881 6480464 rottlerin inhibits the reaction [sodium arsenate results in increased phosphorylation of MARCKS protein] CTD PMID:11796722 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:735485 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of MARCKS mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735485 6480464 [S-(1 more ... CTD PMID:35811015 sarin decreases expression ISO RGD:735485 6480464 Sarin results in decreased expression of MARCKS mRNA CTD PMID:19522546 SB 431542 increases expression ISO RGD:735485 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of MARCKS protein CTD PMID:25670856 selenium atom increases expression ISO RGD:735485 6480464 Selenium results in increased expression of MARCKS mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:735485 6480464 Silicon Dioxide analog results in decreased expression of MARCKS mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:10881 6480464 Silver results in decreased expression of MARCKS mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:10881 6480464 Silver results in decreased expression of MARCKS mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:10881 6480464 rottlerin inhibits the reaction [sodium arsenate results in increased phosphorylation of MARCKS protein] CTD PMID:11796722 sodium arsenate increases phosphorylation ISO RGD:10881 6480464 sodium arsenate results in increased phosphorylation of MARCKS protein CTD PMID:11796722 sodium arsenite decreases expression ISO RGD:735485 6480464 sodium arsenite results in decreased expression of MARCKS mRNA CTD PMID:16507463 sodium aurothiomalate decreases expression ISO RGD:735485 6480464 Gold Sodium Thiomalate results in decreased expression of MARCKS mRNA CTD PMID:19192274 succimer multiple interactions ISO RGD:10881 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKS mRNA CTD PMID:21641980 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of MARCKS mRNA CTD PMID:30047161 sulforaphane decreases expression ISO RGD:735485 6480464 sulforaphane results in decreased expression of MARCKS mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:735485 6480464 Sunitinib results in increased expression of MARCKS mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:10881 6480464 Tamoxifen affects the expression of MARCKS mRNA CTD PMID:17555576 temozolomide increases expression ISO RGD:735485 6480464 Temozolomide results in increased expression of MARCKS mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:735485 6480464 Testosterone results in increased expression of MARCKS mRNA CTD PMID:33359661 testosterone enanthate affects expression ISO RGD:735485 6480464 testosterone enanthate affects the expression of MARCKS mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:10881 6480464 Carbon Tetrachloride affects the expression of MARCKS mRNA CTD PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of MARCKS protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MARCKS mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of MARCKS mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of MARCKS mRNA CTD PMID:25729387 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of MARCKS mRNA CTD PMID:30047161 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MARCKS mRNA CTD PMID:33387578 triclosan increases expression ISO RGD:735485 6480464 Triclosan results in increased expression of MARCKS mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of MARCKS mRNA CTD PMID:30589522 triticonazole decreases expression EXP 6480464 triticonazole results in decreased expression of MARCKS mRNA CTD PMID:36084822 uranium atom affects expression ISO RGD:735485 6480464 Uranium affects the expression of MARCKS mRNA CTD PMID:15672453 valproic acid decreases methylation ISO RGD:735485 6480464 Valproic Acid results in decreased methylation of MARCKS gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:735485 6480464 Valproic Acid results in decreased expression of MARCKS mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:735485 6480464 Valproic Acid results in increased expression of MARCKS mRNA CTD PMID:24849673 valproic acid affects expression ISO RGD:735485 6480464 Valproic Acid affects the expression of MARCKS mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:10881 6480464 Vancomycin results in decreased expression of MARCKS mRNA CTD PMID:18930951 vincristine increases expression ISO RGD:735485 6480464 Vincristine results in increased expression of MARCKS mRNA CTD PMID:23649840 zinc atom decreases expression ISO RGD:735485 6480464 Zinc deficiency results in decreased expression of MARCKS mRNA CTD PMID:18356318 zinc(0) decreases expression ISO RGD:735485 6480464 Zinc deficiency results in decreased expression of MARCKS mRNA CTD PMID:18356318 zoledronic acid increases expression ISO RGD:735485 6480464 zoledronic acid results in increased expression of MARCKS mRNA CTD PMID:24714768
